An observational study in MAFLD, Metabolic Abnormalities and Obesity & Overweight, sponsored by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. Recruiting at 1 site in Bangladesh. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-13.
Sponsored by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · Observational
Metabolic dysfunction-associated fatty liver disease (MAFLD) is an increasingly recognized cause of chronic liver disease and is closely linked with obesity, metabolic abnormalities, and nutritional status. Data on the frequency of MAFLD and its associated metabolic and nutritional factors in rural populations of Bangladesh are not up to date.
This study aims to determine the frequency of MAFLD and to evaluate its association with nutritional status and metabolic risk factors among adults in a rural population of Bangladesh. Eligible participants will undergo clinical assessment, anthropometric measurements, laboratory evaluation of metabolic parameters, and abdominal ultrasonography for the detection of hepatic steatosis. Nutritional status will be assessed using standard anthropometric and clinical criteria.
The findings of this study are expected to provide baseline epidemiological data on MAFLD in rural Bangladesh and to help identify associated metabolic and nutritional risk factors.
11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 114 across 2,154 observational studies indexed under Obesity.
Browse Obesity studies →Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh is the lead sponsor of 128 studies on the registry; 22 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Place of study:
Shimulia Union, Ashulia, Savar, Dhaka, Bangladesh
Study Population: All adults of two villages of Shimulia Union who will give their consent to participate in the study
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Frequency of MAFLD in a rural population of Bangladesh
Time frame: From December 2025 to October 2026
Plan to share: Undecided — The data contain personal health and clinical information, and participants have not provided consent for data sharing beyond the objectives of this study. To protect participant privacy and confidentiality, access to individual-level data will be restricted to the study investigators. Only aggregate, de-identified results will be reported in publications and presentations.
Started Dec 2025 (actual). Primary completion is estimated for Oct 2026, 10 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh →